ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:

Dictionar de medicamente online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dictionar medical online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Puteti trimite articole cu tema medicala la
adresa de email

Solutie antistress!
Construieste poduri :)
Joc, Construieste podul, Cargo Bridge

Prinde pisica neagra :)
Prinde pisica neagra- Chat Noir - Flash game

GSK's Response to Media Coverage about Paediatric HIV/AIDS Clinical Trials in US

Over the years, GlaxoSmithKline has supported many trials conducted by the Paediatric AIDS Clinical Trial Group (PACTG), one of the pre-eminent organizations in the world for evaluating treatments for HIV -infected children and adolescents. The PACTG designs and implements the studies. Companies like GSK will choose to provide medicine, funding, or not participate, based on a review of the trial design; but ultimate approval, control and execution of the study are the responsibility of the PACTG.

Regulatory agencies, including the FDA, are interested in understanding how medicines affect children so they can be appropriately prescribed. Therefore the FDA encourages studies in paediatric patients.

However, such trials must be conducted under the most stringent standards, and in compliance with all local laws and regulations regarding legal authority in the case of minors. GSK, in partnering with the NIH in finding solutions for paediatric patients infected with HIV/AIDS, relies on the PACTG investigators to adhere to all federal and local laws governing those trials.

GlaxoSmithKline (GSK) is one of the world's leading pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information on the Orange Card, or general company information, visit GlaxoSmithKline on the World Wide Web at http://www.gsk.com.

Inquiries:
UK Media Inquiries: Phil Thomson (020) 8047 5502
David Mawdsley (020) 8047 5502
Chris Hunter-Ward (020) 8047 5502
US Media Inquiries: Nancy Pekarek (215) 751 7709
Mary Anne Rhyne (919) 483 2839
Patricia Seif (215) 751 7709
European Analyst/Investor Inquiries: Duncan Learmouth (020) 8047 5540
Anita Kidgell (020) 8047 5542
US Analyst/ Investor Inquiries: Frank Murdolo (215) 751 7002
Tom Curry (215) 751 5419





GSK rãspunsul la Media Coverage pediatric despre HIV / SIDA în studiile clinice în SUA - GSK's Response to Media Coverage about Paediatric HIV/AIDS Clinical Trials in US - articole medicale engleza - startsanatate